Physician profile

Walter C Lin

Plastic Surgery · San Francisco, CA

NPI 1679862635

$68,422.92

in general payments reported to CMS, 2019-2025

37 companies · $47K in 2025

The $47K reported for 2025 was more than what 98% of Plastic Surgery providers received nationally (typical 2025 total: $380).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program$40,150.00
Travel and Lodging$11,823.11
Food and Beverage$6,208.81

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Alafair Biosciences, INC. $52,451.71 2023-2025 Versawrap
Axogen $9,399.40 2019-2025 Avance Nerve Graft, Axoguard Nerve Cap, Axoguard Ha+ Nerve Protector
Tactile Systems Technology INC $2,598.54 2019-2025 Flexitouch Plus, Entre Plus, Nimbl
Baxter Healthcare $667.22 2019-2025
Polynovo North America LLC $417.10 2022-2025 Novosorb Btm
Stryker Corporation $373.42 2025 Variax, Gamma
Avita Medical Americas, LLC $366.38 2021-2025 Recell, Permeaderm, Cohealyx
Biocircuit Technologies INC $196.91 2025 Nerve Tape
Tulavi Therapeutics, INC. $195.70 2025 Allay Nerve Cap - Small Nerve Set
Integra Lifesciences Corporation $186.05 2020-2025 Integra, Primatrix, Integra Dermal Regeneration Template
Exactech, INC. $171.11 2024
Urgo Medical North America, LLC $153.01 2023-2025 Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Urgok2, Drawtex Hydroconductive Wound Dressing With Levafiber 4x4
Polarityte, INC. $141.80 2019-2021
Access Pro Medical, LLC $112.65 2025 Matriderm
Electronic Waveform Lab, INC. $103.53 2023-2024
Show all 37 companies
CompanyGeneral paymentsYearsTop products
Orthofix Medical, INC. $102.99 2022-2025 Physio-Stim, Accelstim
Bioventus LLC $96.97 2019-2025 Exogen Ultrasound Bone Healing System
Endo Pharmaceuticals INC. $89.99 2019
Smith+Nephew, INC. $63.64 2021-2022
Vertex Pharmaceuticals Incorporated $62.95 2025
Vericel Corporation $59.23 2020-2021
Pacira Pharmaceuticals Incorporated $44.21 2019-2025 Exparel
Osiris Therapeutics INC. $40.25 2019
Medela LLC $35.46 2019
Mimedx Group, INC. $34.65 2024
Checkpoint Surgical, INC $33.90 2022
Derma Sciences, INC. $31.38 2019
Acell, INC. $29.57 2019
Solventum Corporation $29.26 2024 V.A.C.Instill
Mallinckrodt Enterprises LLC $19.56 2019
Mallinckrodt Hospital Products INC. $18.27 2020
Acacia Pharma INC $17.82 2021
Davol INC. $17.76 2022
Innovation Technologies INC $17.41 2020
Evolution Surgical, INC $15.63 2023
Ossur Americas, INC. $15.17 2024 I-Digits Quantum
Molnlycke Health Care US, LLC $12.32 2020

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Walter C Lin

$68,422.92

in general payments reported 2019-2025

Years
2019-2025
Top company
Alafair Biosciences, INC.
Context
The $47K reported for 2025 was more than what 98% of Plastic Surgery providers received nationally (typical 2025 total: $380).

https://glasscript.com/doctor/1208048/walter-c-lin

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.